Can you buy a weight loss injection over the counter in the UK?

What clinical trials showed, and why regulators responded with prescription controls

NICE's appraisal of tirzepatide (TA1026, published December 2024) drew on SURMOUNT-1, a 72-week trial involving 2,539 adults with obesity. Participants on the highest dose achieved average body-weight reductions of around 20–21%. That is a clinically significant result by any measure, and it helped drive the MHRA's decision to license Mounjaro for weight management in the UK.

Results of that scale also attracted enormous public interest, and, inevitably, sellers willing to exploit it. The MHRA responded by reinforcing that these are Prescription-Only Medicines and by running enforcement operations that led to the seizure of around 20 million doses of illegally traded weight loss medicines with an estimated street value of roughly £45 million. In October 2025, the first UK site manufacturing counterfeit tirzepatide pens was raided in Northampton, and if you want to understand what a legitimate weight loss injection service looks like in contrast, our dedicated page sets out the full picture. Fake pens have in some cases contained insulin, causing serious harm.

The prescription requirement isn't bureaucracy for its own sake. It exists because the medicines carry real contraindications: a history of medullary thyroid carcinoma, certain gastrointestinal conditions, and concurrent use of other glucose-lowering agents all require clinical assessment before a prescriber can confirm suitability. You can read the NHS's patient-level overview of tirzepatide on the NHS medicines page for a plain-English summary of who should not use it. The prescription step is the mechanism that catches those situations before harm occurs.

What 'over the counter' actually means for weight loss, and where the line sits in UK law

Over-the-counter medicines are those a pharmacist can supply without a prescription: paracetamol, antihistamines, some low-dose orlistat (a fat-absorption reducer available as Alli). Orlistat at the 60mg strength sits in the Pharmacy (P) category, meaning a pharmacist can sell it after a brief consultation, without a prescription from a doctor. That is the outer boundary of what UK law allows for weight management without a prescription.

Mounjaro and Wegovy sit in an entirely different category. The Human Medicines Regulations 2012 define them as POMs precisely because they act systemically, require dose titration by a clinician, interact with oral contraceptives in ways that need managing, and carry monitoring requirements that a brief counter conversation cannot safely cover. For anyone researching how weight loss injections work in the UK, understanding that legal boundary is the starting point.

It is also worth spending sixty seconds on a single practical check: look up any online pharmacy you are considering on the GPhC pharmacy register. A legitimate UK online pharmacy will have a GPhC premises registration number displayed on its site, you can verify it in under a minute. If it isn't there, stop.

What legitimate private access looks like, and the eligibility picture

A regulated online pharmacy can legally supply Mounjaro or Wegovy after a GPhC-registered Independent Prescriber has reviewed your case. That review covers your BMI, relevant medical history, current medicines, and any contraindications. It isn't a rubber stamp, a prescriber can and does decline applications where clinical suitability isn't established.

For private access, the licensed eligibility criteria follow the medicines' UK SmPCs: adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as hypertension, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. For some ethnic backgrounds, UK guidance applies thresholds 2.5 kg/m² lower. BMI alone is never the whole picture, the prescriber assesses the full clinical context, including which option suits you best from the 3 weight loss injections currently available in the UK. If you are wondering whether you meet the criteria, the overview of our treatment options explains the process and what the free consultation covers.

NHS access follows NICE's stricter criteria. As of June 2025, the NHS is prescribing tirzepatide to adults with a BMI of 40 or above who have four or more qualifying conditions; a second cohort covering BMI 35–39.9 with four or more conditions opened in June 2026. For people who don't meet those thresholds or who don't want to wait, a regulated private pharmacy is the legal alternative. You can learn more about NHS access routes for weight loss injections separately.

Side effects, monitoring, and why self-prescribing carries specific risks

The most common side effects of GLP-1 and dual GIP/GLP-1 medicines are gastrointestinal: nausea is reported frequently, alongside loose stools, constipation, reflux, and burping. These are typically most noticeable after a new pen is started or a dose steps up, and they often ease within a couple of weeks. Dose titration (starting low and increasing gradually) exists specifically to reduce their severity, which is one reason a prescriber manages the schedule rather than the patient choosing their own pace.

Less commonly but more seriously, the MHRA highlighted acute pancreatitis in a Drug Safety Update for GLP-1 medicines in January 2026. Severe, persistent stomach pain that spreads toward the back, with or without vomiting, needs urgent medical attention. Patients can report suspected side effects directly through the MHRA Yellow Card scheme, a route that also accepts reports of suspect or counterfeit sellers.

Anyone sourcing these medicines from a seller who dispenses without clinical assessment loses the monitoring layer that catches complications early. There is no dose-review process, no prescriber contact if something goes wrong, and no guarantee the medicine is genuine. Our page on weight loss injection r covers what a responsibly managed injection programme involves, including the ongoing clinical oversight that keeps patients safe. For a broader look at how these medicines fit into a treatment plan, the weight loss treatment overview covers the clinical context, and our guide to m injection for weight loss explains the specifics of Mounjaro's mechanism and how it is administered. And if you have specific questions about the injection process itself, our FAQs address many of the practical points patients raise most often.